Media Releases  – 

BioHorizons Camlog to showcase at EuroPerio11 its latest innovations in biomaterials designed to help advance oral regeneration

The company will showcase its latest biomaterials and highlight the advanced technology behind its two implant systems, both featuring a shared connection. During the event, BioHorizons Camlog will host educational sessions in the form of a workshop and a Corporate Forum.

BioHorizons Camlog is pleased to announce its participation in EuroPerio11, one of the world's leading congresses for periodontology and implantology, taking place from 14 to 16 May 2025 in Vienna, Austria. The event will feature a rich and varied scientific programme, including live surgery, interactive sessions, and more.

Visitors to the BioHorizons Camlog booth can explore the latest innovations in biomaterials including Striate+ and the newly launched bone substitute CeraOss® HYA. The spotlight will also be on CONELOG® PL and Tapered Pro Conical, two implants featuring a user-friendly, shared connection.

"We are thrilled to be part of EuroPerio11 in 2025," said Bianka Wilson, Co-CEO of BioHorizons Camlog. "We are especially looking forward to our workshop on sustainable implant therapy, where participants will gain valuable insights into precision planning, minimally invasive techniques, and cutting-edge advancements in biomaterials. Additionally, our Corporate Forum on next-generation biomaterials for immediate dental implants will offer in-depth discussions on the latest strategies for optimizing implant success."

On Wednesday, 14 May 2025, 13:45 to 16:45, during our workshop, Gerhard Iglhaut, DDS, PhD from Germany will discuss the critical impact of precise 3D implant positioning on the long-term stability of implant-supported restorations. The session will cover precision planning and positioning with surgical templates, the importance of peri-implant tissue maintenance, and the use of innovative allogenic and xenogeneic hard and soft tissue replacement materials.

In the Corporate Forum on Thursday, 15 May 2025, 12:30 to 14:00, Homa Zadeh, DDS, from USA, Gonzalo Blasi, DDS, from Spain and Edward Pat Allen, DDS, from the USA will discuss next-generation biomaterials for immediate dental implants: challenges and solutions. The forum will be moderated by Hom-Lay Wang, DDS, from the USA. The Corporate Forum will provide valuable insights into the latest developments in biomaterials for immediate dental implants and will cover key strategies for optimising implant success.

To join BioHorizons Camlog at EuroPerio11 and to learn more about the company’s innovative products, please visit the team at booth C20.

 
 

Download press release

Download image

 

Contacts
 

Veronica Vargas
Head, Global Events and Education – BioHorizons Camlog
Telephone: +1 205 541 7068
E-mail: veronica.vargas@camlog.com

Stefanie Fleige
Director, Corporate Media Relations – EMEA
Telephone: +49172 6433548
E-mail: stefanie.fleige@henryschein.de

Marta F. Sánchez-Oro
Senior Manager, Corporate Media Relations – EMEA
Telephone: +34 609 68 55 24
E-mail: marta.sanchez-oro@henryschein.com

 
About BioHorizons Camlog
 

BioHorizons Camlog is a leading supplier of premium dental implant systems, restorative components, a comprehensive line of biologics products and digital solutions. It is committed to developing evidence-based and scientifically proven products, as well as continuing education adhering to highest standards.

Headquartered in the U.S. and Europe, BioHorizons Camlog’s geographic positions allow it to efficiently serve direct subsidiaries in the Americas and Western Europe, as well as its entire distribution network in more than 90 countries around the world.

The company is part of Henry Schein Inc., a solutions company for healthcare professionals powered by a network of people and technology. With approximately 25,000 Team Schein Members worldwide, Henry Schein’s network of trusted advisors provides over 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes.

For more information, visit www.biohorizonscamlog.com and www.henryschein.com.